From March 9 to 13, 2012, theheart.org conducted a survey to gauge cardiologists' opinions on statin safety following an FDA-mandated labeling change, warning that the drugs may increase blood glucose and HbA1c and potentially lead to reversible memory loss/confusion. Here's what they told us.